glp-1 advertising crackdown news Hims cancels plans to sell compounded pill after FDA backlash GLP-1 Spending Hit $5.8 Billion
Description
Peer review Peer review information Nature Reviews Clinical Oncology thanks M
10.14814/phy2.13852 66 RobertsonR
Who Is a Good Candidate for Semaglutide GLP-1 Weight Loss Injections
His protocol: tirzepatide (Mounjaro) at 2.5mg/week, half the lowest standard pen dose, with targeted resistance work to protect muscle
35 If you cant compound an oral peptide (which is incredibly difficult), you need to find a way to offer a significant difference for the patients who fail on the pill
